These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 26502132)
1. The Roles of Providers and Patients in the Overuse of Prostate-Specific Antigen Screening in the United States. Guo F; He D Ann Intern Med; 2015 Oct; 163(8):650-1. PubMed ID: 26502132 [No Abstract] [Full Text] [Related]
2. States renewing attention to prostate cancer. Rossiter C NCSL Legisbrief; 2012 Sep; 20(36):1-2. PubMed ID: 23072022 [No Abstract] [Full Text] [Related]
3. Is Prostate-Specific Antigen Screening "Proven Ineffective Care"? Barry MJ; Albertsen PC Ann Intern Med; 2016 May; 164(10):687-8. PubMed ID: 26902323 [No Abstract] [Full Text] [Related]
4. Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC). Bokhorst LP; Zappa M; Carlsson SV; Kwiatkowski M; Denis L; Paez A; Hugosson J; Moss S; Auvinen A; Roobol MJ BJU Int; 2016 Nov; 118(5):677-680. PubMed ID: 27104278 [TBL] [Abstract][Full Text] [Related]
5. Risks of PSA screening now better understood. Peres J J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893 [No Abstract] [Full Text] [Related]
6. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role? Jackson BR Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565 [No Abstract] [Full Text] [Related]
7. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important? Barry MJ; Mulley AJ J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451 [No Abstract] [Full Text] [Related]
8. Lung cancer screening gets risk-specific. Peres J J Natl Cancer Inst; 2013 Jan; 105(1):1-2. PubMed ID: 23257155 [No Abstract] [Full Text] [Related]
10. Early detection of prostate cancer. Taneja SS Urol Clin North Am; 2014 May; 41(2):xi-xii. PubMed ID: 24725495 [No Abstract] [Full Text] [Related]
11. Summaries for patients. Screening smarter, not harder, for prostate cancer. Ann Intern Med; 2013 Feb; 158(3):I-30. PubMed ID: 23381056 [No Abstract] [Full Text] [Related]
12. The need for active surveillance for low risk prostate cancer. Drost FH; Roobol MJ Expert Rev Anticancer Ther; 2017 Jun; 17(6):487-489. PubMed ID: 28406334 [No Abstract] [Full Text] [Related]
13. Alternative prostate cancer screening strategies. Labrecque M; Aprikian A Ann Intern Med; 2013 May; 158(10):778. PubMed ID: 23689773 [No Abstract] [Full Text] [Related]
14. Alternative prostate cancer screening strategies--in response. Gulati R; Etzioni R Ann Intern Med; 2013 May; 158(10):778-9. PubMed ID: 23689774 [No Abstract] [Full Text] [Related]
15. Laurence Klotz on the Controversy Surrounding Screening for Prostate Cancer. Klotz L Oncology (Williston Park); 2016 Aug; 30(8):694, 764. PubMed ID: 27528237 [No Abstract] [Full Text] [Related]
17. [Does a low PSA at 60 years old exclude the risk of developing prostate carcinoma?]. Zürcher S Rev Med Suisse; 2014 Jun; 10(434):1316. PubMed ID: 25073308 [No Abstract] [Full Text] [Related]
18. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. Belpomme D; Irigaray P J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186 [No Abstract] [Full Text] [Related]
19. Early detection of prostate cancer: can we have our cake and eat it too? Masterson TA; Cary C; Cheng L Expert Rev Anticancer Ther; 2016; 16(3):247-9. PubMed ID: 26760708 [No Abstract] [Full Text] [Related]